Rinki Deo

the results of Paxlovid rebound data. Special thanks to my mentor @DrJLi , and all coauthors @Dr_MChoudhary @joseph_eron @Dr_Carlee_Moser @GreningerLab @JudithCurrier @DaveySmithMD and others @ACTGNetwork

Paxlovid rebound is everywhere. Ever wondered how viral & rebound looks like in untreated individuals? Check out our new paper in @AnnalsofIM Key findings: Viral or symptom rebound is common in ACTIV-2 participants who received

Excited to be at CROI-2023@Seattle and present our work on symptom and viral rebound in untreated COVID-19 infection.

3) Oral #171, 11:08am. You've heard of Paxlovid rebound, but how common is symptom and viral rebound during natural, untreated COVID-19 recovery? Come find out the answer by @DeoR83 @Dr_MChoudhary and the @ACTGNetwork ACTIV-2 study team